Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 35, 2023 - Issue 3
1,767
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Adverse pregnancy outcomes among pregnant women living with HIV in Hubei province, China: prevalence and risk factors

ORCID Icon, , , , , , ORCID Icon, ORCID Icon & show all
Pages 351-358 | Received 19 Oct 2021, Accepted 31 Jan 2022, Published online: 19 Feb 2022

References

  • Andany, N., & Loutfy, M. R. (2013). HIV protease inhibitors in pregnancy. Drugs, 73(3), 229–247. https://doi.org/10.1007/s40265-013-0017-3
  • Chen, F. F., Guo, W., Qin, Q. Q., Cai, C., & Cui, Y. (2018). Spatial-temporal distribution of newly detected HIV/AIDS cases among aged 15 years or older women in China, 2010-2016. Zhonghua liu Xing Bing xue za zhi = Zhonghua Liuxingbingxue Zazhi, 39(6), 739–744. https://doi.org/10.3760/cma.j.issn.0254-6450.2018.06.009
  • China. (2008). Implementationplanforpreventionofmother-to-childtransmissionofHIV(revised). http://www.gov.cn/gzdt/2008-05/30/content_999767.htm
  • China. (2011). Implementation plan for prevention of mother-to-child transmission of HIV, syphilis, and hepatitis B. https://view.officeapps.live.com/op/view.aspx?src=http%3A%2F%2Fwww.gov.cn%2Fgzdt%2Fatt%2Fatt%2Fsite1%2F20110224%2F001e3741a2cc0ecfebbf01.doc&wdOrigin=BROWSELINK
  • China. (2017). Implementation plan for prevention of mother-to-child transmission of HIV, syphilis, and hepatitis B. https://www.chinacdc.cn/jkzt/fybj/xgzcfg/201801/P020180104574896456689.pdf
  • Choi, H., Kim, M. H., Lee, S. J., Kim, E. J., Lee, W., Jeong, W., Jung, I. Y., Ahn, J. Y., Jeong, S. J., Ku, N. S., Baek, J. H., Choi, Y. H., Kim, H. Y., Kim, J. M., & Choi, J. Y. (2018). Pregnancy rates and outcomes of HIV-infected women in korea. Journal of Korean Medical Science, 33(47), e296. https://doi.org/10.3346/jkms.2018.33.e296
  • Dong, Y., Guo, W., Gui, X., Liu, Y., Yan, Y., Feng, L., & Liang, K. (2020). Preventing mother to child transmission of HIV: Lessons learned from China. BMC Infectious Diseases, 20(1), 792. https://doi.org/10.1186/s12879-020-05516-3
  • Dos Reis, H. L. B., Boldrini, N. A. T., Rangel, A. F. R., Barros, V. F., Merçon de Vargas, P. R., & Miranda, A. E. (2020). Placental growth disorders and perinatal adverse outcomes in Brazilian HIV-infected pregnant women. PloS One, 15(4), e0231938. https://doi.org/10.1371/journal.pone.0231938
  • Ekouevi, D. K., Coffie, P. A., Ouattara, E., Moh, R., Amani-Bosse, C., Messou, E., Sissoko, M., Anglaret, X., Eholié, S. P., Danel, C., & Dabis, F. (2011). Pregnancy outcomes in women exposed to efavirenz and nevirapine: An appraisal of the IeDEA West Africa and ANRS databases, abidjan, côte d'Ivoire. Journal of Acquired Immune Deficiency Syndromes, 56(2), 183–187. https://doi.org/10.1097/QAI.0b013e3181ff04e6
  • Ezechi, O. C., David, A. N., Gab-Okafor, C. V., Ohwodo, H., Oladele, D. A., Kalejaiye, O. O., Ezeobi, P. M., Gbajabiamila, T. A., Adu, R. A., Oke, B., Musa, Z. A., Ekama, S. O., Ilesanmi, O., Odubela, O., Somefun, E. O., Herbertson, E. C., Onwujekwe, D. I., & Ujah, I. A. (2012). Incidence of and socio-biologic risk factors for spontaneous preterm birth in HIV positive Nigerian women. BMC Pregnancy and Childbirth, 12(1), 93. https://doi.org/10.1186/1471-2393-12-93
  • Ezechi, O. C., Gab-Okafor, C. V., Oladele, D. A., Kalejaiye, O. O., Oke, B. O., Ohwodo, H. O., Adu, R. A., Ekama, S. O., Musa, Z., Onwujekwe, D. I., David, A. N., & Ujah, I. A. (2013). Pregnancy, obstetric and neonatal outcomes in HIV positive Nigerian women. African Journal of Reproductive Health, 17(3), 160–168. PMID: 24069778.
  • Favarato, G., Townsend, C. L., Peters, H., Sconza, R., Bailey, H., Cortina-Borja, M., Tookey, P., & Thorne, C. (2019). Stillbirth in Women Living With HIV Delivering in the United Kingdom and Ireland: 2007-2015. Journal of Acquired Immune Deficiency Syndromes, 82(1), 9–16. https://doi.org/10.1097/QAI.0000000000002087
  • Floridia, M., Tamburrini, E., Masuelli, G., Martinelli, P., Spinillo, A., Liuzzi, G., Vimercati, A., Alberico, S., Maccabruni, A., Pinnetti, C., Frisina, V., Dalzero, S., & Ravizza, M. (2017). Rate, correlates and outcomes of repeat pregnancy in HIV-infected women. HIV Medicine, 18(6), 440–443. https://doi.org/10.1111/hiv.12473
  • Ganguly, S., Chakraborty, D., Goswami, D. N., Biswas, S., Debnath, F., & Saha, M. K. (2021). High Stillbirth among HIV-infected pregnancy in West Bengal, India; A retrospective cohort study. Japanese Journal of Infectious Diseases, 74(5), 424–428. https://doi.org/10.7883/yoken.JJID.2020.811
  • Gray, G. E., & McIntyre, J. A. (2007). Hiv and pregnancy. BMJ, 334(7600), 950–953. https://doi.org/10.1136/bmj.39176.674977.AD
  • Haeri, S., Shauer, M., Dale, M., Leslie, J., Baker, A. M., Saddlemire, S., & Boggess, K. (2009). Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy. American Journal of Obstetrics and Gynecology, 201(3), 315.e311–315. https://doi.org/10.1016/j.ajog.2009.06.017
  • Hu, F., Liang, J. J., Lu, J. J., Hu, Y. F., Hu, Y., Yu, J., Zou, X. W., Ma, Y. H., & Lin, S. F. (2019). Effects of antiretroviral therapy and HIV exposure in utero on adverse pregnancy and infant outcomes: A prospective cohort study in guangzhou, China. Biomedical and Environmental Sciences, 32(10), 719–729. https://doi.org/10.3967/bes2019.092
  • Ikumi, N. M., Malaba, T. R., Pillay, K., Cohen, M. C., Madlala, H. P., Matjila, M., Anumba, D., Myer, L., Newell, M.-L., & Gray, C. M. (2021). Differential impact of antiretroviral therapy initiated before or during pregnancy on placenta pathology in HIV-positive women. AIDS (London, England), 35(5), 717–726. https://doi.org/10.1097/QAD.0000000000002824
  • Jiayu, N., Ling, J., & Zhen, Y. (2011). Analysis on the influencing factors of adverse pregnancy outcomes in natural pregnancy women. Clinical Medicine &Engineering, 28(11), 1589–1590. https://doi.org/10.3969/j.issn.1674-4659.2021.11.1589
  • Kreitchmann, R., Li, S. X., Melo, V. H., Fernandes Coelho, D., Watts, D. H., Joao, E., Coutinho, C. M., Alarcon, J. O., & Siberry, G. K. (2014). Predictors of adverse pregnancy outcomes in women infected with HIV in Latin America and the Caribbean: a cohort study. BJOG : an international journal of obstetrics and gynaecology, 121(12), 1501–1508. https://doi.org/10.1111/1471-0528.12680
  • Lancaster, K. E., Kwok, C., Rinaldi, A., Byamugisha, J., Magwali, T., Nyamapfeni, P., Salata, R. A., & Morrison, C. S. (2015). Incident pregnancy and pregnancy outcomes among HIV-infected women in Uganda and Zimbabwe. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 131(3), 255–259. https://doi.org/10.1016/j.ijgo.2015.06.035
  • Marcus, U. (2019). HIV infections and HIV testing during pregnancy, Germany, 1993 to 2016. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 24(48), 1900078. https://doi.org/10.2807/1560-7917.ES.2019.24.48.1900078
  • Myer, L., Phillips, T. K., Zerbe, A., Brittain, K., Lesosky, M., Hsiao, N.-Y., Remien, R. H., Mellins, C. A., McIntyre, J. A., & Abrams, E. J. (2018). Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial. PLoS Medicine, 15(3), e1002547. https://doi.org/10.1371/journal.pmed.1002547
  • O'Brien, B. E., Williams, P. L., Huo, Y., Kacanek, D., Chadwick, E. G., Powis, K. M., Correia, K., Haddad, L. B., Yee, L. M., Chakhtoura, N., Dola, C., & Van Dyke, R. B. (2020). Repeat pregnancies Among US women living With HIV in the SMARTT study: Temporal changes in HIV Disease status and Predictors of preterm birth. Journal of Acquired Immune Deficiency Syndromes, 85(3), 346–354. https://doi.org/10.1097/QAI.0000000000002445
  • Onono, M., Odwar, T., Wahome, S., Helova, A., Bukusi, E. A., Hampanda, K., Turan, J., & Abuogi, L. (2021). Behavioral interventions can mitigate adverse pregnancy outcomes Among women conceiving on ART and those initiated on ART during pregnancy: Findings from the MOTIVATE trial in southwestern Kenya. Journal of Acquired Immune Deficiency Syndromes, 86(1), 46–55. https://doi.org/10.1097/QAI.0000000000002521
  • Ørbaek, M., Thorsteinsson, K., Moseholm Larsen, E., Katzenstein, T. L., Storgaard, M., Johansen, I. S., Pedersen, G., Bach, D., Helleberg, M., Weis, N., & Lebech, A. M. (2020). Risk factors during pregnancy and birth-related complications in HIV-positive versus HIV-negative women in Denmark, 2002-2014. HIV Medicine, 21(2), 84–95. https://doi.org/10.1111/hiv.12798
  • Pan, Y., Zhang, S., Wang, Q., Shen, H., Zhang, Y., Li, Y., Yan, D., & Sun, L. (2016). Investigating the association between prepregnancy body mass index and adverse pregnancy outcomes: A large cohort study of 536 098 Chinese pregnant women in rural China. BMJ Open, 6(6), e011227. https://doi.org/10.1136/bmjopen-2016-011227
  • Queensland Clinical Guideline: Gestational diabetes mellitus (GDM). https://www.health.qld.gov.au/.
  • Queensland Clinical Guideline: Hypertension and pregnancy. https://www.health.qld.gov.au/.
  • Queensland Clinical Guideline: Preterm labor and birth. https://www.health.qld.gov.au/.
  • Rittenhouse, K. J., Mwape, H., Nelson, J. A. E., Mwale, J., Chipili, G., Price, J. T., Hudgens, M., Stringer, E. M., De Paris, K., Vwalika, B., & Stringer, J. S. A. (2021). Maternal HIV, antiretroviral timing, and spontaneous preterm birth in an urban Zambian cohort: The role of local and systemic inflammation. Aids (london, England), 35(4), 555–565. https://doi.org/10.1097/QAD.0000000000002808
  • Rollins, N. C., Coovadia, H. M., Bland, R. M., Coutsoudis, A., Bennish, M. L., Patel, D., & Newell, M.-L. (2007). Pregnancy outcomes in HIV-infected and uninfected women in rural and urban South Africa. Journal of acquired immune deficiency syndromes (1999), 44(3), 321–328. https://pubmed.ncbi.nlm.nih.gov/17195768 https://doi.org/10.1097/QAI.0b013e31802ea4b0
  • Sarkar, A., Balogun, K., Guzman Lenis, M. S., Acosta, S., Mount, H. T., & Serghides, L. (2020). In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice. PloS One, 15(11), e0242513. https://doi.org/10.1371/journal.pone.0242513
  • Tarar, S. H., Afzal, M., Atta, H., & Shah, S. M. A. (2021). Obstetric outcomes of Human Immunodeficiency Virus positive mothers in tertiary care hospital. Journal of the Pakistan Medical Association, 71, 69–72. https://doi.org/10.47391/jpma.552
  • Theron, G., Brummel, S., Fairlie, L., Pinilla, M., McCarthy, K., Owor, M., Chinula, L., Makanani, B., Violari, A., Moodley, D., Chakhtoura, N., Browning, R., Hoffman, R., & Fowler, M. G. (2021). Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy. Journal of Biochemistry and Molecular Biology, 73(2), e312–e320. https://doi.org/10.1093/cid/ciaa805
  • Thorne, C., Patel, D., & Newell, M.-L. (2004). Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS (London, England), 18(17), 2337–2339. https://pubmed.ncbi.nlm.nih.gov/15577551 https://doi.org/10.1097/00002030-200411190-00019
  • Transcript of the National Health Commission's regular press conference in 2018. (2018). http://www.scio.gov.cn/xwfbh/gbwxwfbh/xwfbh/wsb/Document/1642083/1642083.htm.
  • Uthman, O. A., Nachega, J. B., Anderson, J., Kanters, S., Mills, E. J., Renaud, F., Essajee, S., Doherty, M. C., & Mofenson, L. M. (2017). Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis. The lancet. HIV, 4(1), e21–e30. https://doi.org/10.1016/S2352-3018(16)30195-3
  • Venkatesh, K. K., Farhad, M., Fenton, T., Moodley, D., Naik, S., Nakabiito, C., Fairlie, L., Fowler, M. G., Stringer, J. S. A., & Chi, B. H. (2019). Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis. AIDS (London, England), 33(15), 2403–2413. https://doi.org/10.1097/QAD.0000000000002367
  • WHO. (2005). Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Guidelines on care, treatment, and support for women living with HIV/AIDS and their children in resource-constrained settings. https://www.who.int/hiv/pub/mtct/en/arvdrugsguidelines_web.pdf
  • WHO. (2010). Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Recommendations for a public health approach. http://apps.who.int/iris/bitstream/handle/10665/75236/9789241599818_eng.pdf;sequence=1
  • WHO. (2013). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. https://www.who.int/publications/i/item/9789241505727
  • WHO. (2019). HIV/AIDs data and statistics. https://www.who.int/data/gho/data/themes/topics/indicator-groups/indicator-group-details/GHO/prevention-of-mother-to-child-transmission